Recent Finacing
Recent Raise
T3 Pharmaceuticals engineers live bacteria using a proprietary type III secretion system to selectively colonize solid tumors and deliver therapeutic proteins into eukaryotic cancer cells.
Focus Areas
Recent Investors
Total Raised
Funding rounds
Investors
See the team members at T3 Pharmaceuticals.
